Target intelligence / Profile preview

Transmembrane protein 132D (TMEM132D)

Target
TMEM132D
Molecular classification
Transmembrane protein, Cell adhesion molecule, Immunoglobulin superfamily
01

Overview

Transmembrane protein 132D is a cell-surface adhesion molecule that is highly expressed in the brain and mature oligodendrocytes[1][3]. It features five conserved extracellular domains, including three tandem immunoglobulin domains and a cohesin domain homologue, marking it as part of an ancient and structurally unique cell adhesion protein family[1]. Its intracellular domain contains docking sites for protein phosphatase 1 (PP1) and a WAVE regulatory complex interacting motif, linking extracellular neuronal interactions to actin cytoskeleton dynamics[1]. TMEM132D is implicated in the regulation of neuronal morphology, motility, and migration, and has been associated with several diseases, including panic disorder, non-syndromic hearing loss, and cancer[1]. Its domain architecture and evolutionary conservation suggest physiologically significant roles in CNS cell connectivity and response to genetic variants, warranting deeper investigation as a disease-related target[1][3].

Other names
TMEM132DHBE120KIAA1944MOLTPPP1R153Mature oligodendrocytes transmembrane proteinMature OL transmembrane proteinProtein phosphatase 1 regulatory subunit 153
02

Mechanism of action

Not established; since no approved drugs target TMEM132D directly, no mechanisms have been characterized.

03

Biological functions

Cell adhesionNeuronal morphology regulationActin cytoskeleton linkageCell migration
04

Disease associations

Neurological disease (panic disorder, hearing loss)Cancer (mutations have been associated)Intracranial aneurysm (possible roles, based on variant association)

Beyond the preview

Go deeper on Transmembrane protein 132D (TMEM132D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 132D (TMEM132D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call